Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 201-225 of 949 matching filings.

Per page
25
Current page
9
3

FORM 3

Filing date
13 Jul 2021
Reporting date
09 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
13 Jul 2021
Reporting date
08 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-43603

SCHEDULE 13D/A

Filing date
15 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-256093

EFFECT filing

Filing date
24 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-256093

FORM 424B3

Filing date
24 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-256093

FORM S-1

Filing date
13 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
11 May 2021
Reporting date
07 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
11 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
05 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Apr 2021
Reporting date
23 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-43603

SC 13D/A

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
05 Apr 2021
Reporting date
02 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Mar 2021
Reporting date
29 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
24 Mar 2021
Reporting date
24 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .